What AXT (AXTI) Said on Its Q3 Earnings Call
AXT reported Q3 non-GAAP net income of $26.8M ($0.41 per share), up from $11.9M ($0.19 per share) in Q2. The company signed a $43.5M prepayment agreement with Lumentum and saw its indium phosphide backlog exceed $500M. AXT plans to double its capacity by 2027 and expects Q4 non-GAAP earnings of $0.57-$0.59 per share.
How this was made

The 30-second read
Why it matters
The call combines earnings and forward guidance with supply-chain and capacity signals, including a long-term Lumentum agreement and explicit 2026-2027 capacity targets.
Market read
Traders can update expectations for Q4 earnings and near-term revenue recognition based on guidance, backlog, and the shipment-linked structure of the Lumentum prepayment.
What to watch
The Lumentum prepayment is recorded as a liability until shipments; investors should track actual shipping cadence versus revenue recognition timing, especially around permit-dependent substrate/raw-material realizations.
Background
AXT is a compound semiconductor substrate supplier (notably indium phosphide) used in optoelectronic devices for data-center and AI networking.
Ticker impact
AXT reported Q3 results and guided Q4 non-GAAP EPS to $0.57-$0.59, plus disclosed a $43.5M Lumentum wafer supply prepayment and >$500M InP backlog.
Likely upward bias as the market prices in stronger demand and clearer Q4 revenue recognition, offset by any concerns about execution of the 2026-2027 capacity ramp.
The article contains fresh, company-specific disclosures: Q3 financials, Q4 EPS guidance, a long-term Lumentum supply agreement with a sizable prepayment, and explicit backlog and capacity targets for 2026-2027.
Market effects
Reinforces demand strength for indium phosphide-based components used in high-speed optical transceivers, which can lift sentiment across compound semiconductor substrate supply chains.
China capacity expansion financing for indium phosphide could affect regional supply expectations and competitive dynamics.
AI optics buildout remains a global capex theme, with InP substrate supply acting as a potential constraint.
Counterpoint
Backlog and demand commentary may not fully translate into shipments if customer allocations tighten or capacity conversion slips into 2027.
Key entities
- companyAXT, Inc.
Reported Q3 results, guided Q4 EPS, and discussed InP backlog, capacity expansion, and a long-term Lumentum supply agreement.
- customer_partnerLumentum
Entered into a long-term supply agreement with AXT including a $43.5M wafer prepayment.
- subsidiaryTongmei
Majority-owned subsidiary that entered a definitive agreement for private-equity financing to expand InP and raw-material capacity in China.


